Clinical Trials Directory

Trials / Unknown

UnknownNCT02264964

Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis

Duration and Adverse Events of Non-cuffed Catheter in Patients With Hemodialysis : a Multicenter Prospective Cohort Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,400 (estimated)
Sponsor
Shanghai Changzheng Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The duration and adverse events of non-cuffed catheter in patients with hemodialysis will be investigated by multicenter prospective cohort. Totally, 1,400 patients with chronic renal failure requiring hemodialysis will be enrolled. 900 patients will be given right internal jugular catheterization, and the other 500 patients unsuitable for right internal jugular catheterization will receive femoral catheterizations. Every patient will be followed-up for six months. During following-up period, the duration time and adverse events of non-cuffed catheter will be recorded in details, including inadequate hemodialysis blood flow, venous stenosis, venous thrombosis, infection, catheter thrombosis and so on. The central vein will be evaluated by CT Angiography to identify its stenosis at last visit after 6 months. This multicentre trial will provide evidence to develop guideline for duration time of using non-cuffed catheter.

Conditions

Interventions

TypeNameDescription
DEVICEGamCath®Using non-cuff GamCath® catheter in patients with chronic renal failure requiring hemodialysis to building short-term vascular access in femoral vein.
PROCEDUREArteriovenous fistula creation500 patients will undergo AVF creation in either arm for femoral vein catheterization group.
DEVICEGamCath®Using non-cuff GamCath® catheter in patients with chronic renal failure requiring hemodialysis to building short-term vascular access in right internal jugular vein.
PROCEDUREArteriovenous fistula creation900 patients will undergo AVF creation in left arm for internal jugular vein catheterization group.

Timeline

Start date
2015-01-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-10-15
Last updated
2014-10-15

Source: ClinicalTrials.gov record NCT02264964. Inclusion in this directory is not an endorsement.